Andlauer Healthcare Group Inc. Financials

Market Capitalization C$1.71 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	27.49
Forward PE	23.61
Price to Sales TTM	C$2.62
Price to Book MRQ	C$4.22
Enterprise to Revenue	2.73
Enterprise to EBITDA	16.08

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	10.06%
Operating Margin	14.92%
Return on Assets TTM	8.83%
Return on Equity TTM	14.92%

Income Statement

Revenue TTM	C$651,251,008
Revenue per Share TTM	C$15.93
Quarterly Revenue Growth	1.80%
Gross Profit TTM	C$147,481,000
EBITDA	C$168,428,000
Net Income to Common TTM	C$65,501,000
Diluted EPS TTM	C$1.58
Quarterly Earnings Growth YoY	6.20%

Balance Sheet

Total Cash MRQ	C$35,994,000
Total Cash per Share MRQ	C$0.92
Total Debt MRQ	C$
Total Debt to Equity MRQ	39.31
Current Ratio MRQ	1.44
Book Value per Share MRQ	C$10.29

Cash Flow

Operating Cash Flow TTM	C$126,941,000
Levered Free Cash Flow TTM	C$97,076,752

AND Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	18,484,100
Float Shares	17,881,811
Avg 10 Volume	39,549
Avg 30 Volume	None
Shares Short	48,017
Short Ratio	2.21
Short % of Shares	%
% Held by Insiders	1.82%
% Held by Institutions	69.78%

Stock Price Summary

Beta	0.66
Fifty Two Week Low	C$36.43
Fifty Two Week High	C$48.00
Fifty Two Week Change	13.75%
Day 50 MA	C$40.48
Day 200 MA	C$40.27

Dividends and Splits

Forward Annual Dividend Rate	C$0.44
Forward Annual Dividend Yield	0.95%
Trailing Annual Dividend Rate	C$0.40
Trailing Annual Dividend Yield	0.87%
Payout Ratio	25.32%
Dividend Date	2024-10-15
Ex Dividend Date	2024-09-27
Last Split Factor
Last Split Date